Tuesday, July 5, 2011

ReportsnReports – Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation


Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation

Report Summary
The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.
The Asia-Pacific orthopedic biomaterials report covers the following countries:
  • Japan
  • South Korea
  • Australia
  • China
The segments covered in this report include:
  • autologous bone grafts,
  • bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
  • hyaluronic acid (HA) viscosupplementation,
  • bone morphogenetic protein (BMP) growth factor therapy
  • autologous chondrocyte implantation (ACI)
The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment in 2010, increasing almost 7% over the previous year.
This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Latest Market Research Reports:
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
at